Navkar Corporation Ltd
₹81.87
+5.07 (6.60%)
Fri, 06 Nov 2026, 10:28 pm
Navkar Corporation News
Navkar Corp parent JSW Infra Q2FY27 results
Navkar Corporation's ultimate holding company, JSW Infrastructure, reported a 17% YoY rise in operating revenue to ₹1,481 crore for Q2FY27. Net cash stood at ₹1,693 crore.
27 Oct 2026
companies
Navkar Corp Q2 net profit jumps 168% YoY
Navkar Corporation reported a net profit of ₹118 million in Q2, up from ₹44 million YoY. EBITDA rose to ₹333 million, though margins dipped slightly to 14.9%.
23 Oct 2026
companies
Navkar Corporation wins ₹48 crore cargo terminal deal
Navkar Corporation received approval for construction of a Gati Shakti Multi-Modal Cargo Terminal, with the contract valued at around ₹48 crore.
14 Oct 2026
companies
Navkar Corp to attend three investor meets in Sep
Navkar Corporation Ltd will participate in investor meetings with Morgan Stanley, Jefferies, and J.P. Morgan in September 2026. The schedule includes group and one-on-one sessions.
09 Sept 2026
companies
JSW Infrastructure Q1 FY27 revenue rises 18%
JSW Infrastructure reported an 18% YoY rise in revenue to ₹1,445 crore for Q1 FY27. Operating EBITDA grew 16% to ₹674 crore, while PAT stood at ₹358 crore.
21 Jul 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo